VIBHA |
VIBHAVADI MEDICAL CENTER PUBLIC COMPANY LIMITED |
Services/Health Care Services |
SETWB |
CG Report:   |
|
|
|
|
Price (B.) |
52 Week High/Low |
P/E (X) |
P/BV (X) |
Paid-up (MB.) |
Market Cap (MB.) |
EV (MB.) |
EBITDA (MB.) |
EV/EBITDA |
2.36 |
2.82 / 2.10 |
15.49 |
2.44 |
1,357.60 |
32,039.04 |
47,944.17 | 842.94 |
14.52 |
|
News |
Date/Time |
Subject |
21 Jun 2022 12:39 | Report on the results of the Exercise of VIBHA-W3 (F53-5) |
20 Jun 2022 17:16 | Report on the results of the Exercise of VIBHA-W3 (F53-5) |
16 Jun 2022 12:52 | Report on the results of the Exercise of VIBHA-W3 (F53-5) |
15 Jun 2022 17:17 | Report on the results of the Exercise of VIBHA-W3 (F53-5) |
13 Jun 2022 17:05 | Shareholders meeting's resolution |
more
|
Company Profile |
Address |
51/3 NGAMWONGWAN RD., LATYAO, JATUJAK Bangkok 10900 |
Telephone |
0-2579-9680-4, 0-2561-1258-67, 0-2941-2800 |
Fax |
0-2561-1466, 0-2561-1462 |
URL |
http://www.vibhavadi.com |
Establish Date |
01/3/1986 |
Listed Date |
26/03/1992 |
IPO Price (Baht) |
31.00 |
@Par10.00 Baht |
IPO Financial Advisory |
MEC FAR EAST INTERNATIONAL PUBLIC COMPANY LIMITED
|
Par |
0.10 Baht |
Last Par Change |
Old 1.00 : New 0.10 @ 22/05/2015 |
Free Float |
22 Mar 2022 |
19 Mar 2021 |
% /Shareholders |
29.88% |
13,949 |
33.40% |
13,189 |
|
Foreign Shareholders |
0.58% (As of 28/06/2022) |
Foreign Limit |
40.00% |
NVDR Shareholders |
0.93% (As of 28/06/2022) |
|
|
5 Yr Price Performance (Adjusted Price) |
|
Price Performance (Adjusted Price) |
Compare to Stock (%) |
Compare to Sector (%) |
Compare to Market (%) |
5 Days |
-0.84 |
-1.99 |
-2.08 |
20 Days |
-8.53 |
-6.16 |
-5.99 |
60 Days |
-4.84 |
-4.70 |
0.52 |
120 Days |
-11.28 |
-20.54 |
-8.66 |
YTD |
-10.61 |
-19.98 |
-7.07 |
P/E (X) |
15.49 |
20.55 |
18.78 |
P/BV (X) |
2.44 |
4.18 |
1.67 |
Turnover Ratio (%) |
0.01 |
0.19 |
0.92 |
|
Top 10 Major Shareholders(@17 Jun 2022) |
Share |
% |
1. |
บริษัท เอฟแอนด์เอส 79 จำกัด |
2,083,909,966 |
15.35 |
2. |
MR. CHAISITH VIRIYAMETTAKUL |
2,037,000,000 |
15.00 |
3. |
บริษัท สินแพทย์ จำกัด |
1,199,859,166 |
8.84 |
4. |
บริษัท โรงพยาบาลรามคำแหง จำกัด (มหาชน) |
962,605,200 |
7.09 |
5. |
บริษัท โรงพยาบาลเจ้าพระยา จำกัด (มหาชน) |
804,334,195 |
5.92 |
6. |
MR. PISUTH VIRIYAMETTAKUL |
584,900,000 |
4.31 |
7. |
บริษัท โรงพยาบาลวิภาราม จำกัด |
564,043,133 |
4.15 |
8. |
MR. PHITJIT WIRIYAMETTAKUL |
473,000,000 |
3.48 |
9. |
นายแพทย์ เอื้อชาติ กาญจนพิทักษ์ |
174,802,916 |
1.29 |
10. |
MR. PHICHIT WIRIYAMETTAKUL |
171,000,000 |
1.26 |
Management |
Position |
1. |
Mr. NIKOM WAIRATPANIJ |
CHAIRMAN OF THE BOARD DIRECTOR / INDEPENDENT DIRECTOR / AUDIT COMMITTEE |
2. |
Mr. CHAISITH VIRIYAMETTAKUL |
CHAIRMAN OF EXECUTIVE DIRECTOR / DIRECTOR |
3. |
Mr. PHIJIT WIRIYAMETTAKUL |
MANAGING DIRECTOR / DIRECTOR |
4. |
Mr. CHAMNAN CHANAPAI |
DIRECTOR |
5. |
Mr. PONGPAT PATANAVANICH |
DIRECTOR |
6. |
Miss RUKKAGEE KANJANAPITAK |
DIRECTOR |
7. |
Mrs. BAVORNPHAN RATHPRASERT |
DIRECTOR |
8. |
Mr. SITTHI PANUPATTANAPONG |
DIRECTOR |
9. |
Mrs. YADA PUTTHKAYON |
DIRECTOR |
10. |
Mr. PRAMUK UNACHAK |
DIRECTOR |
11. |
Mr. PITCHAYA SOMBURANASIN |
DIRECTOR |
12. |
GEN. BOONLOET CHUNTARAPAS |
INDEPENDENT DIRECTOR |
13. |
Mr. CHAINARIN SAIRUNGSRI |
INDEPENDENT DIRECTOR / AUDIT COMMITTEE |
14. |
Mr. SIROTE SWASDIPANICH |
INDEPENDENT DIRECTOR / CHAIRMAN OF THE AUDIT COMMITTEE |
15. |
Mr. PRASERT SRIURANPONG |
INDEPENDENT DIRECTOR / AUDIT COMMITTEE |
|
Statistics |
YTD 28 Jun 2022 |
2021 30 Dec 2021 |
2020 30 Dec 2020 |
Listed share (M.) |
13,575.87 |
13,575.87 |
13,575.87 |
Market Cap (MB.) |
32,039.04 |
35,840.29 |
19,956.52 |
Price (B./share) |
2.36 |
2.64 |
1.47 |
BVPS (B./Share) |
0.97 |
0.75 |
0.57 |
P/BV (X) |
2.44 |
3.50 |
2.60 |
P/E (X) |
15.49 |
24.95 |
67.71 |
Turnover Ratio (%) |
15.78 |
68.02 |
7.94 |
Value Trade/Day (MB.) |
46.92 |
85.83 |
6.80 |
Beta |
0.31 |
0.32 |
0.56 |
|
Rate of Return |
YTD |
2021 |
2020 |
Price Change (%) |
-10.61 |
79.59 |
-17.88 |
Dividend Yield (%) |
2.12 |
1.52 |
2.99 |
Payout Ratio |
0.33 |
0.38 |
2.03 |
Dividend Policy |
Not less than 80% of net profits after deducting legal reserves and other reserves (if any) |
Dividend |
Operation Period |
Dividend/Share |
Unit |
Payment Date |
Type |
01 Jan 2021 - 31 Dec 2021 |
0.05 |
Baht |
25 May 2022 |
Cash |
01 Jan 2020 - 31 Dec 2020 |
0.04 |
Baht |
24 May 2021 |
Cash |
01 Jan 2019 - 31 Dec 2019 |
0.045 |
Baht |
27 May 2020 |
Cash |
|
|
Auditor (Effective Until 31/12/2022) |
MR. PERADATE PONGSATHIANSAK/DHARMNITI AUDITING CO., LTD. |
MR. THANAWUT PIBOONSAWAT/DHARMNITI AUDITING CO., LTD. |
MR. SUWAT MANEEKANOKSAKUL/DHARMNITI AUDITING CO., LTD. |
MISS SORAYA TINTASUWAN/DHARMNITI AUDITING CO., LTD. |
Miss POTJANARAT SIRIPIPAT/DHARMNITI AUDITING CO., LTD. |
Miss ROONGNAPHA SAENGCHAN/DHARMNITI AUDITING CO., LTD. |
Miss TECHINEE PORNPENPOB/DHARMNITI AUDITING CO., LTD. |
|
F/S Year ended |
31/12 |
Latest Type of Report |
Unqualified opinion with an emphasis of matters |
|
|
Statement of Financial Position (MB.) |
3M/2022 (01/01/22 -31/03/22) |
3M/2021 (01/01/21 -31/03/21) |
2021 (01/01/21 -31/12/21) |
2020 (01/01/20 -31/12/20) |
2019 (01/01/19 -31/12/19) |
Accounting Type |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Cash And Cash Equivalents |
466.98 |
589.22 |
511.79 |
338.29 |
602.86 |
A/R Net |
1,136.65 |
734.52 |
982.77 |
639.66 |
592.60 |
Inventories |
206.58 |
161.58 |
182.44 |
164.93 |
174.56 |
Current Assets |
3,199.99 |
1,975.98 |
2,965.73 |
1,521.33 |
1,718.79 |
PP&E Net |
8,566.83 |
8,133.04 |
8,558.63 |
7,970.09 |
7,024.74 |
Non-Current Assets |
26,323.99 |
20,406.33 |
25,460.94 |
19,653.68 |
17,911.06 |
Total Assets |
29,523.98 |
22,382.31 |
28,426.67 |
21,175.02 |
19,629.85 |
OD |
3,700.78 |
2,875.47 |
3,821.51 |
2,605.90 |
2,677.94 |
A/P Net |
546.96 |
374.04 |
552.77 |
376.94 |
431.45 |
Current portion of LT |
1,215.88 |
1,140.04 |
1,345.08 |
1,065.16 |
843.18 |
Current Liabilities |
7,064.98 |
5,559.30 |
7,374.38 |
5,304.90 |
5,359.02 |
Non-Current Liabilities |
6,095.89 |
5,450.32 |
5,795.71 |
5,136.10 |
3,899.17 |
Total Liabilities |
13,160.87 |
11,009.62 |
13,170.09 |
10,441.00 |
9,258.19 |
Authorized Capital |
1,493.91 |
1,493.91 |
1,493.91 |
1,493.91 |
1,493.78 |
Paid-Up Capital |
1,357.59 |
1,357.59 |
1,357.59 |
1,357.59 |
1,326.46 |
Premium (Discount) on Share Capital |
2,718.14 |
2,718.14 |
2,718.14 |
2,718.14 |
2,438.33 |
Retained Earnings (Deficit) |
4,333.19 |
2,775.72 |
3,878.48 |
2,598.52 |
2,614.08 |
Treasury Stock |
- |
- |
- |
- |
- |
Shares Of The Company Held By Subsidiaries |
- |
- |
- |
- |
- |
Other Components Of Equity |
4,742.97 |
1,919.23 |
4,230.06 |
1,496.41 |
1,409.71 |
- Surplus (Deficits) |
- |
- |
- |
- |
- |
Shareholders' Equity |
13,151.88 |
8,770.68 |
12,184.26 |
8,170.65 |
7,788.59 |
Minority Interest |
3,211.23 |
2,602.01 |
3,072.31 |
2,563.37 |
2,583.08 |
more |
|
Statement of Comprehensive Income (MB.) |
3M/2022 (01/01/22 -31/03/22) |
3M/2021 (01/01/21 -31/03/21) |
2021 (01/01/21 -31/12/21) |
2020 (01/01/20 -31/12/20) |
2019 (01/01/19 -31/12/19) |
Accounting Type |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Revenue From Operations |
2,303.60 |
1,598.50 |
7,419.51 |
6,024.45 |
6,545.89 |
Other Income |
26.83 |
25.38 |
111.90 |
121.71 |
116.16 |
Total Revenues |
2,395.56 |
1,679.43 |
7,873.84 |
6,338.25 |
6,872.48 |
Costs |
1,532.01 |
1,125.34 |
5,218.86 |
4,485.88 |
4,778.58 |
Selling And Administrative Expenses |
269.34 |
222.67 |
946.31 |
925.04 |
953.47 |
Total Cost And Expenses |
1,801.35 |
1,348.01 |
6,199.70 |
5,410.92 |
5,732.05 |
EBITDA |
842.94 |
438.84 |
2,896.83 |
1,303.67 |
1,813.73 |
Depre. & Amor. |
160.53 |
108.18 |
501.00 |
438.69 |
413.38 |
EBIT |
682.41 |
330.66 |
2,395.83 |
864.98 |
1,400.35 |
Net Profit : Owners Of The Parent |
454.71 |
191.90 |
1,805.05 |
449.80 |
809.05 |
EPS (B.) |
0.03 |
0.01 |
0.13 |
0.03 |
0.06 |
more |
|
Statement of Cash Flow (MB.) |
3M/2022 (01/01/22 -31/03/22) |
3M/2021 (01/01/21 -31/03/21) |
2021 (01/01/21 -31/12/21) |
2020 (01/01/20 -31/12/20) |
2019 (01/01/19 -31/12/19) |
Accounting Type |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Operating Cash Flow |
430.99 |
396.07 |
1,671.76 |
1,094.74 |
1,526.56 |
Investing Cash Flow |
-332.28 |
-513.44 |
-1,928.65 |
-1,669.28 |
-3,087.83 |
Financing Cash Flow |
-143.52 |
368.30 |
430.39 |
309.98 |
1,857.01 |
Net Cash Flow |
-44.81 |
250.93 |
173.49 |
-264.56 |
295.73 |
more |
|
Ratios |
3M/2022 |
3M/2021 |
2021 |
2020 |
Current Ratio (X) |
0.45 |
0.36 |
0.40 |
0.29 |
ROE (%) |
18.87 |
6.03 |
17.74 |
5.64 |
ROA (%) |
10.59 |
4.26 |
9.66 |
4.24 |
D/E (X) |
0.80 |
0.97 |
0.86 |
0.97 |
Total Asset Turnover (X) |
0.33 |
0.30 |
0.32 |
0.31 |
Gross Profit Margin (%) |
33.50 |
29.60 |
29.66 |
25.54 |
EBIT Margin (%) |
28.49 |
19.69 |
30.43 |
13.65 |
Net Profit Margin (%) |
21.98 |
13.90 |
24.78 |
8.50 |
Capital Movement (Last 3 Year) |
Date |
CA Type |
Changed paid up share |
Paid up share |
Par |
No Information Found |
|
Growth Rate (%) |
3M/2022 |
3M/2021 |
2021 |
2020 |
Sales Growth |
44.11 |
-2.38 |
23.16 |
-7.97 |
COGs Growth |
36.14 |
-4.86 |
16.34 |
-6.13 |
Total Revenue Growth |
42.64 |
-1.55 |
24.23 |
-7.77 |
Total Expense Growth |
33.63 |
-5.80 |
14.58 |
-5.60 |
Net Profit Growth |
136.95 |
27.04 |
301.30 |
-44.40 |
Cash Cycle |
3M/2022 |
3M/2021 |
2021 |
2020 |
A/R Turnover (Times) |
8.68 |
9.34 |
9.15 |
9.78 |
Avg. Collection Period (Days) |
42.03 |
39.09 |
39.91 |
37.33 |
Inventory Turnover (Times) |
30.56 |
25.12 |
30.05 |
26.43 |
Avg. Inventory Period (Days) |
11.94 |
14.53 |
12.15 |
13.81 |
A/P Turnover (Times) |
15.46 |
12.06 |
13.46 |
11.10 |
Avg. Payment Period (Days) |
23.61 |
30.26 |
27.11 |
32.89 |
Cash Cycle (Days) |
30.36 |
23.36 |
24.94 |
18.25 |
|
Trading Sign (Latest) |
Trading Alert |
Posted Date |
Lifted Date |
No Information Found |
Market Alert (Latest) |
No Information Found |
more
|
|
Other Securities |
Securities Name |
- |
|
|
 |
Source: www.set.or.th (Copyright © The Stock Exchange of Thailand) |
|